Lyrica (pregabalin) is not inherently dangerous when taken as prescribed, but it does carry real risks that range from common nuisances like dizziness and weight gain to rare but serious problems like respiratory depression and suicidal thoughts. Whether it’s “bad” for you depends on your dose, what other medications you take, and how your body responds. Here’s what the evidence actually shows.
How Lyrica Works in Your Body
Lyrica binds to a specific protein on nerve cells that helps control calcium flow. By doing this, it dials down overactive nerve signaling in the brain and spinal cord. This is why it’s prescribed for such different conditions: nerve pain, fibromyalgia, seizures, and generalized anxiety disorder. All of these involve nerves firing too much or too easily. It’s classified as a Schedule V controlled substance in the United States, meaning the DEA considers it to have a low but real potential for misuse.
The Most Common Side Effects
In clinical trials, the side effects that showed up far more often in people taking Lyrica than in those taking a placebo were:
- Dizziness: 31% of Lyrica users vs. 9% on placebo
- Drowsiness: 22% vs. 7%
- Weight gain: 9% gained 7% or more of their body weight within 14 weeks, compared to 2% on placebo
- Blurred vision: 7% vs. 2%
- Swelling in hands and feet: 6% vs. 2%
- Difficulty concentrating: reported at more than twice the rate of placebo
These numbers come from premarketing trials, so they reflect what happens in a controlled setting. In everyday use, dizziness and drowsiness are by far the most frequent complaints, and they tend to be worst in the first few weeks before your body adjusts.
Weight Gain Over Time
Short-term weight gain is common enough to notice in trials, but the longer you take Lyrica, the more it adds up. In a group of 333 people with diabetes who took Lyrica for at least two years, the average weight gain was about 11.4 pounds. For comparison, people on placebo in shorter trials gained less than a pound and a half. The weight gain appears to be dose-related, meaning higher doses typically lead to more pounds. This is one of the top reasons people consider stopping the medication.
Effects on Thinking and Memory
The “brain fog” that many Lyrica users describe is not imagined. A study published in Neurology tested 32 healthy volunteers, giving half of them pregabalin and the other half a placebo for 12 weeks. The pregabalin group performed significantly worse on three of six cognitive tests, covering processing speed, verbal fluency, and the ability to filter out distracting information. The effects were mild to moderate, but they correlated directly with blood levels of the drug: higher levels meant worse performance. Two participants dropped out early specifically because of difficulty thinking, even at low doses.
This matters because these were healthy people, not patients already dealing with pain or fatigue that could cloud thinking. The cognitive effects appear to be caused by the drug itself.
Swelling and Heart Concerns
Up to 20% of people taking Lyrica develop peripheral edema, the puffy swelling in ankles, feet, or hands caused by fluid retention. This has raised concerns about whether Lyrica could worsen heart failure. A large study looking specifically at patients with pre-existing heart failure found that Lyrica did not increase the risk of heart failure flare-ups. Still, the edema itself can be uncomfortable and alarming. In at least one documented case, a patient with no cardiac history developed significant swelling throughout the body that resolved completely after stopping the drug.
The Opioid Interaction Risk
This is where Lyrica can become genuinely dangerous. Combining it with opioids, benzodiazepines, or other sedating substances has been linked to respiratory failure, coma, and death. Doses above 300 mg per day alongside opioids are particularly associated with an increased risk of opioid-related death. The UK’s medicines regulator received 122 reports of respiratory depression linked to pregabalin over a seven-year period, and in roughly two-thirds of those cases, another sedating drug was also involved.
Even without other drugs in the picture, there is limited evidence that Lyrica alone can cause serious breathing problems, particularly in older adults and people with underlying lung conditions or kidney impairment.
Suicidal Thoughts
The FDA requires a warning on all anti-seizure medications, including Lyrica, about an increased risk of suicidal thoughts and behavior. This applies regardless of why you’re taking the drug. The risk is relatively small in absolute terms, but it’s consistent enough across the drug class that monitoring for mood changes, worsening depression, or unusual behavior is part of the prescribing guidance.
Dependence and Withdrawal
Lyrica is not as addictive as opioids or benzodiazepines, but it can produce physical dependence. The DEA noted during its scheduling review that an unusually high percentage of clinical trial participants experienced euphoria, and the drug’s pleasant psychoactive effects make intermittent misuse plausible. It does not, however, produce the same reinforcing cycle that drives compulsive use of stronger substances.
Stopping Lyrica suddenly can cause insomnia, nausea, headaches, anxiety, diarrhea, excessive sweating, and cravings. For people with seizure disorders, abrupt discontinuation can trigger more frequent or more severe seizures. Suicidal thoughts can also emerge or worsen during withdrawal.
The standard approach is to taper gradually over several weeks. A typical schedule from a moderate dose might reduce the amount by roughly 25% to 50% each week over about a month. People on higher doses or those who have taken it for years often need a slower taper, and if withdrawal symptoms flare up during the process, temporarily holding at a stable dose before continuing to reduce is common.
Kidney Function Matters
Lyrica is cleared almost entirely through the kidneys. If your kidney function is reduced, the drug builds up in your system faster and stays longer, amplifying both its effects and its side effects. People whose kidney filtration rate drops below 60 mL per minute need a dose reduction of at least 50%, with further cuts for more severe impairment. This is one reason why older adults, who naturally lose kidney function with age, are at higher risk for serious side effects like respiratory depression and excessive sedation.
Who Faces the Highest Risk
Lyrica is most likely to cause serious harm in people who fall into specific categories: those taking opioids or other sedating medications, older adults (over 65), people with compromised lung function, and those with significant kidney disease. If none of those apply to you, the most likely downsides are the common side effects like drowsiness, dizziness, weight gain, and mental fogginess, which are bothersome but not dangerous. For people in higher-risk groups, the stakes are meaningfully different, and the balance between Lyrica’s benefits and its risks shifts accordingly.